Skip to content
10-Q

Quarterly Report

Biostax Corp.

0001493152-23-029368

← back to feed
Filed
Aug 18, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Aug 18, 2023 83.62M sh
Cash And Equivalents Q2 2023 · Jun 30, 2023 $17.43K
Cash And Equivalents Q2 2023 · Dec 31, 2022 $150.49K
Current Liabilities Q2 2023 · Jun 30, 2023 $3.86M
Current Liabilities Q2 2023 · Dec 31, 2022 $3.48M
Total Liabilities Q2 2023 · Jun 30, 2023 $3.86M
Total Liabilities Q2 2023 · Dec 31, 2022 $3.48M
Current Assets Q2 2023 · Jun 30, 2023 $17.43K
Current Assets Q2 2023 · Dec 31, 2022 $150.49K
Total Assets Q2 2023 · Jun 30, 2023 $758.67K
Total Assets Q2 2023 · Dec 31, 2022 $963.72K
Shares Diluted Q2 2023 · Jun 30, 2022 7.8M sh
Shares Diluted Q2 2023 · Jun 30, 2022 590.82K sh
Operating Cash Flow Q2 2023 · Jun 30, 2022 −$560.77K
Stockholders Equity Q2 2023 · Jun 30, 2022 −$6.57M
Stockholders Equity Q2 2023 · Dec 31, 2021 −$7.95M
Eps Diluted Q2 2023 · Jun 30, 2022 $0.23
Eps Diluted Q2 2023 · Jun 30, 2022 −$1.29
Eps Basic Q2 2023 · Jun 30, 2022 $2.57
Eps Basic Q2 2023 · Jun 30, 2022 −$1.29
Sga Expense Q2 2023 · Jun 30, 2022 $292.12K
Sga Expense Q2 2023 · Jun 30, 2022 $473.73K
Net Income Q2 2023 · Jun 30, 2022 $1.79M
Net Income Q2 2023 · Jun 30, 2022 −$763.7K
Operating Income Q2 2023 · Jun 30, 2022 −$292.12K
Operating Income Q2 2023 · Jun 30, 2022 −$473.73K